The empty capsules market has seen considerable growth due to a variety of factors.
• The market size of empty capsules has seen robust growth in the recent past. The market, which stands at $3.21 billion in 2024, is projected to expand to $3.5 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.2%. The notable growth during the historic period is attributed to the evolution in consumer preferences, promising economic conditions, the influence of the Russia-Ukraine conflict, barriers to entry in the industry, and the aging population.
The Empty Capsules market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for empty capsules is anticipated to experience swift expansion in the forthcoming years. The market is projected to hike to $5.28 billion by 2029 with a compound annual growth rate (CAGR) of 10.8%.
The growth during the forecast period can be related to expansion of market size, market solidification, ethical considerations, strict rules and regulations, and rising demand for nutraceuticals and market dynamics. The major trends during the forecast period are product adaptations, sustainable procurement, utilization in vegetarian and vegan products, patient demographics and treatments for chronic diseases, and regional supremacy.
The projected growth of the empty capsules market is expected to be driven by a rise in chronic disease prevalence. Chronic illnesses are typically long-lasting, often persisting for three months or more, and may show a gradual deteriorating progression. Cancer, heart disease, stroke, diabetes, and arthritis are some of the most common chronic diseases. Empty capsules serve to administer various drugs without altering their formula; they are engineered to guarantee efficient drug delivery without negatively affecting any drug formulation. For instance, based on the January 2022 research by the American Cancer Society, a US health organization predicted about 609,360 cancer-related deaths and about 1.9 million new cancer diagnoses in the US in 2022, which equals approximately 1,670 deaths each day. Thus, the rising prevalence of chronic diseases is fueling the expansion of the empty capsules market.
The empty capsules market covered in this report is segmented –
1) By Type: Gelatin Capsules, Non-Gelatin Capsules
2) By Functionality: Immediate-Release Capsules, Sustained-Release Capsules, Delayed-release Capsules
3) By Application: Antibiotic And Antibacterial Drugs, Dietary Supplements, Antacid And Antiflatulent Preparations, Antianemic Preparations, Anti-inflammatory Drugs, Cardiovascular Therapy Drugs, Cough And Cold Drug Preparations, Other Therapeutic Applications
4) By End-User: Pharmaceutical Industry, Nutraceutical Industry, Cosmetic Industry, Research Laboratories
Subsegments:
1) By Gelatin Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules
2) By Non-Gelatin Capsules: Vegetable Capsules, Pullulan Capsules, Other Plant-Based Capsules
Advancements in product development are becoming a significant trend in the empty capsules market. Companies leading the empty capsules industry are introducing new merchandise to reinforce their market position. For instance, Bright Pharma Caps Inc, an Indian pharmaceutical enterprise, unveiled its innovation, Bright-Poly, in August 2023. This product, being the first-ever globally certified organic capsule, is manufactured from USDA-certified organic pullulan. This aligns perfectly with the need for organic encapsulation options in the nutritional supplement industry. As compared to conventional capsules, Bright-Poly capsules, made with NOP certified organic pullulan, purified water, and alginates, are devoid of surfactants and chemical additives.
Major companies operating in the empty capsules market include:
• ACG Group
• CapsCanada Corporation
• HealthCaps India Limited
• Natural Capsules Ltd.
• Bright Pharma Caps Inc.
• Suheung Co. Ltd.
• Roxlor LLC
• Lonza Group AG
• Goerlich Pharma GmbH
• Qualicaps Inc.
• Comed Chemicals Limited
• Wuhan Carma Technology Co. Ltd.
• Nectar Lifesciences Ltd.
• Erawat Pharma Limited
• Medi-Caps Ltd.
• Mitsubishi Chemical Holdings Corporation
• Snail Pharma Industry Co. Ltd.
• Sunil Healthcare Ltd.
• Shanxi Guangsheng Medicinal Capsule Co. Ltd.
• Aenova Group GmbH
• Capsuline Inc.
• Farmacapsulas SA
• Health Pharma
• JC Biotech Pvt. Ltd.
• Lefan Capsule International Inc.
• Nipro Capsule Co. Ltd.
• Qingdao Yiqing Medicinal Capsules Co. Ltd.
• Shaoxing Kangke Capsule Co. Ltd.
• Sunloc Industrial Co. Ltd.
North America was the largest region in the empty capsules market in 2024. The regions covered in the empty capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.